Aditxt (ADTX) Other Non-Current Assets (2019 - 2026)
Aditxt (ADTX) recorded quarterly Other Non-Current Assets of $61586.0 in Q1 2026, little changed quarter-over-quarter from $61586.0 in Q4 2025, and down 65.76% on a YoY basis from $179846.0 in Q1 2025.
Aditxt (ADTX) Other Non-Current Assets (2019 - 2026) Analysis & Trends
Aditxt's Other Non-Current Assets history runs 8 years deep, the most recent figure standing at $61586.0 for Q1 2026.
- In Q1 2026, Other Non-Current Assets fell 65.76% year-over-year to $61586.0; the TTM figure through Mar 2026 stood at $61586.0 (down 65.76% YoY), while the FY2025 annual figure was $61586.0, down 29.75% from the prior year.
- Other Non-Current Assets was $61586.0 for Q1 2026 at Aditxt, roughly flat from $61586.0 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $524548.0 in Q2 2022 to a low of $61586.0 in Q4 2025.
- Historically, Other Non-Current Assets has averaged $224349.2 across 5 years, with a median of $179846.0 in 2025.
- The sharpest annual moves came in 2022 and 2023: Other Non-Current Assets surged 518.07% in 2022, then sank 70.06% in 2023.
- A 5-year view of Other Non-Current Assets shows it stood at $355366.0 in 2022, then tumbled by 70.06% to $106410.0 in 2023, then dropped by 17.61% to $87672.0 in 2024, then fell by 29.75% to $61586.0 in 2025, then changed by 0.0% to $61586.0 in 2026.
- The last three Other Non-Current Assets figures came in at $61586.0 (Q1 2026), $61586.0 (Q4 2025), and $75229.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 12.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 60,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.26 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Aditxt | 2,485.68 | -2.16 Mn | 2,868.00 | 61,586.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 61,586.00 |
| Dec 31, 2025 | 61,586.00 |
| Sep 30, 2025 | 75,229.00 |
| Jun 30, 2025 | 215,946.00 |
| Mar 31, 2025 | 179,846.00 |
| Dec 31, 2024 | 87,672.00 |
| Sep 30, 2024 | 102,042.00 |
| Jun 30, 2024 | 106,982.00 |
| Mar 31, 2024 | 132,496.00 |
| Dec 31, 2023 | 106,410.00 |
| Sep 30, 2023 | 312,265.00 |
| Jun 30, 2023 | 287,265.00 |
| Mar 31, 2023 | 410,306.00 |
| Dec 31, 2022 | 355,366.00 |
| Sep 30, 2022 | 347,555.00 |
| Jun 30, 2022 | 524,548.00 |
| Mar 31, 2022 | 446,837.00 |
| Dec 31, 2021 | 379,250.00 |
| Sep 30, 2021 | 422,108.00 |
| Jun 30, 2021 | 271,832.00 |